NVCR - NovoCure Limited (NVCR) CEO Asaf Danziger on Q4 2020 Results - Earnings Call Transcript

NovoCure Limited. (NVCR) Q4 2020 Results Earnings Conference Call February 25, 2021, 08:00 AM ET Company Participants Gabrielle Fernandes - Director, IR William Doyle - Executive Chairman Asaf Danziger - President, CEO & Director Ashley Cordova - CFO & VP, IR Ely Benaim - Chief Medical Officer Uri Weinberg - Chief Science Officer Pritesh Shah - Chief Commercial Officer Conference Call Participants Jason Bednar - Piper Sandler Greg Gilbert - Truist Securities Lawrence Biegelsen - Wells Fargo Vijay Kumar - Evercore ISI Daniel Clark - Mizuho Securities Jason Wittes - Northland Securities Presentation Operator Ladies and gentlemen, thank you for standing by and welcome to the NovoCure’s Fourth Quarter and Full Year 2020 Earnings Conference Call. At this time all participants line are in a listen-only mode. [Operator Instructions] Please be advised that today’s conference is being recorded. [Operator Instructions] I would now like to hand the conference over to

For further details see:

NovoCure Limited (NVCR) CEO Asaf Danziger on Q4 2020 Results - Earnings Call Transcript